AGLTS barrier isolation technology
It’s advanced. It’s automatic. It’s above everything you have used so far. With over 100 AGLTS installed around the world.
The most advanced GMP compliant glove integrity system for isolators and RABs in the pharmaceutical industry, developed in compliance with the international standard ISO 14644-7 Annex E5.
AGLTS barrier isolation technology features
- Manufacturing materials resistant to sanitizing agents and bio-decontamination processes
- Automatic complete testing procedures
- Parametric testing formulas
- Integrated pneumatic circuit
- Complete encrypted data/reports storage and download via SD card
- Testing time within 8 minutes, depending on both glove material and dimension
- Standard ergonomic docking station made of SS304 (configurations for 4, 5, 6 and 8 testing units available)
- Custom designed docking station made of SS304 available upon specific request
- Low start-up costs
AGLTS barrier isolation technology benefits
- Saving production time in isolated filling lines, stand-alone isolator systems and RABS Technology
- Avoiding operator mistakes
- Detecting small holes in the gloves (≥ 50 μm)
- Data consulting can be done outside the classified environment
AGLTS barrier isolation technology references
EUROPE
Sanofi Pasteur, Marcy-l’Étoile, France
SDN, Naples, Italy
Fresenius Kabi, Isola della Scala, Italy
GSK, Rosia-Sovicille, Italy
Genzyme, Waterford, Ireland
Patheon, Ferentino, Italy
Alvotech Reykjavìk, Iceland
Sanofi Pasteur, Val-de-Reuil, France
Bristol-Myers Squibb, Anagni, Italy
Patheon, Monza, Italy
Kedrion, S. Antimo, Italy
AstraZeneca, Sodertalje, Sweden
Takeda, Singen, Germany
Chiesi Farmaceutici, Parma, Italy
Alexion, Athlone, Ireland
AAA (Novartis Group), Marseille, France
Laboratorio Reig Jofre, Barcelona, Spain
Cyclopharma, Clermond Ferrand, France
M2i, Dublin, Ireland
Pfizer, San Sebastian de Los Reyes, Madrid
AAA (Novartis Group), Murcia, Spain
AAA (Novartis Group), Saragoza, Spain
Universitaetsspital, Basel, Switzerland
Pharmathen, Pallini, Greece
NORTH AMERICA
AAA (Novartis Group), Millburn, USA
Pentec Health, Boothwyn, PA, USA
Celgene, Phoenix, AZ, USA
Pfizer, Andover, MA, USA
Revance, Newark, CA, USA
CENTRAL & SOUTH AMERICA
Libbs, San Paolo, Brasil
Bio-Manguinhos, Rio de Janeiro, Brasil
Novartis, San Paolo, Brasil
OCEANIA
Phebra, Lane Cove West, Australia
Royal Brisbane & Women’s Hospital, Brisbane, Australia
SAHMRI, Adelaide, Australia
EURASIA & MIDDLE EAST
Abdi Ibrahim, Istanbul, Turkey
Wockhardt, Dubai, United Arab Emirates
Deva, Kartepe, Turkey
Deva, Cerkezkoy, Turkey
Mustafa Nevzat İlaç, Istanbul, Turkey
ASIA
Rohto, Mie, Japan
Towa, Yamagata, Japan
JCR, Hyogo, Japan
DS Pharma Animal Health, Osaka, Japan
Nihon Zoki, Hyogo, Japan
Minopagen Pharmaceutical, Kanagawa, Japan
Otsuka Pharmaceutical, Tokushima, Japan
Pfizer, Aichi, Japan
Bristol-Myers Squibb, Aichi, Japan
Astellas Pharma Tech, Shizuoka, Japan
Nipropharma, Akita, Japan
Pfizer, Hangzhou, China
Bharat Serum, Maharashtra, India
Chun Fo Dispensary Ltd., Hong Kong
Chonnam National University Hwasun Hospital, Jeonnam, South Korea
Teva Takeda Yakuhin Ltd, Koka City, Japan
Toyobo, Tokyo, Japan
Shionogi & CO. LTD, Kanegasaki, Japan
Teva Takeda Pharma,Gifu, Japan
Kyowa Hakko Kirin, Gumma, Japan
Nipropharma,Mie, Japan
Toyobo, Shiga, Japan
Nippon Medical & Chemical Instruments, Osaka, Japan
Ayumi Pharmaceutical, Tamagawa, Japan
Documents
-
AGLTS Brochure
Download (2.46 MB)